Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Orhan Sezer

Showing results (71-80 of 109) with videos related to

Pageof 11
Sort By:
Blood|February 3, 2009
Lenalidomide, adriamycin, and dexamethasone (RAD) in patients with relapsed and refractory multiple myeloma: a report from the German Myeloma Study Group DSMM (Deutsche Studiengruppe Multiples Myelom)Stefan Knop, Christian Gerecke, Peter Liebisch, et al.
European Journal of Haematology|November 17, 2007
Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in mantle cell lymphomaUlrike Heider, Ivana von Metzler, Martin Kaiser, et al.
European Journal of Haematology|March 12, 2008
Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myelomaMartin Kaiser, Maren Mieth, Peter Liebisch, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 20, 2011
How to manage neutropenia in multiple myelomaAntonio Palumbo, Jon Bladé, Mario Boccadoro, et al.
Clinical & Developmental Immunology|April 7, 2012
Longitudinal analysis of tetanus- and influenza-specific IgG antibodies in myeloma patientsSebastian Kobold, Tim Luetkens, Britta Marlen Bartels, et al.
Annals of Hematology|September 19, 2003
Diagnosis and treatment of documented infections in neutropenic patients--recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)Dieter Buchheidt, Angelika Böhme, Oliver A Cornely, et al.
American Journal of Hematology|July 27, 2005
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004Morie A Gertz, Ray Comenzo, Rodney H Falk, et al.
Leukemia & Lymphoma|May 6, 2014
Granulocyte-colony stimulating factor response is superior to neutropenia duration in predicting the risk of infection after high-dose chemotherapy for myeloma and lymphomaChristian Straka, Hans Salwender, Brigitte Schnabel, et al.
Blood|November 11, 2006
Circulating proteasome levels are an independent prognostic factor for survival in multiple myelomaChristian Jakob, Karl Egerer, Peter Liebisch, et al.
Bone|March 4, 2008
Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosisRené Rizzoli, Nansa Burlet, David Cahall, et al.
Pageof 11

Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
Blood|February 3, 2009
Lenalidomide, adriamycin, and dexamethasone (RAD) in patients with relapsed and refractory multiple myeloma: a report from the German Myeloma Study Group DSMM (Deutsche Studiengruppe Multiples Myelom)Stefan Knop, Christian Gerecke, Peter Liebisch, et al.
European Journal of Haematology|November 17, 2007
Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in mantle cell lymphomaUlrike Heider, Ivana von Metzler, Martin Kaiser, et al.
European Journal of Haematology|March 12, 2008
Serum concentrations of DKK-1 correlate with the extent of bone disease in patients with multiple myelomaMartin Kaiser, Maren Mieth, Peter Liebisch, et al.
Clinical Lymphoma, Myeloma & Leukemia|December 20, 2011
How to manage neutropenia in multiple myelomaAntonio Palumbo, Jon Bladé, Mario Boccadoro, et al.
Clinical & Developmental Immunology|April 7, 2012
Longitudinal analysis of tetanus- and influenza-specific IgG antibodies in myeloma patientsSebastian Kobold, Tim Luetkens, Britta Marlen Bartels, et al.
Annals of Hematology|September 19, 2003
Diagnosis and treatment of documented infections in neutropenic patients--recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO)Dieter Buchheidt, Angelika Böhme, Oliver A Cornely, et al.
American Journal of Hematology|July 27, 2005
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004Morie A Gertz, Ray Comenzo, Rodney H Falk, et al.
Leukemia & Lymphoma|May 6, 2014
Granulocyte-colony stimulating factor response is superior to neutropenia duration in predicting the risk of infection after high-dose chemotherapy for myeloma and lymphomaChristian Straka, Hans Salwender, Brigitte Schnabel, et al.
Blood|November 11, 2006
Circulating proteasome levels are an independent prognostic factor for survival in multiple myelomaChristian Jakob, Karl Egerer, Peter Liebisch, et al.
Bone|March 4, 2008
Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosisRené Rizzoli, Nansa Burlet, David Cahall, et al.
Pageof 11